UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES
OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOSCRIP,
INC.
|
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
05-0489664
|
(State
of incorporation or organization)
|
|
(I.R.S.
Employer
Identification no.)
|
1600
Broadway, Suite 950, Denver, Colorado
|
|
80202
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
If this form relates to the
registration of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction
A.(c), please check the following box.
ý
|
|
If this form relates to the
registration of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction
A.(d), please check the following box.
¨
|
Securities Act registration statement file number to
which this form relates:
|
Not
Applicable
|
|
(if applicable)
|
Securities to be registered pursuant to Section 12(b) of the
Act:
Title
of each class to be so registered
|
Name
of each exchange on which each class is to be registered
|
Rights
to Purchase Series D Junior Participating Preferred Stock
|
NASDAQ
Global Market
|
Securities to be registered pursuant to Section 12(g) of the
Act:
BIOSCRIP, INC.
INFORMATION REQUIRED IN REGISTRATION
STATEMENT
|
Item 1.
|
Description of Registrant’s Securities to be
Registered.
|
On August 11, 2016, the Board of Directors
(the “
Board
”) of BioScrip, Inc., a Delaware On August 11, 2016, the Board of Directors (the “
Board
”)
of BioScrip, Inc., a Delaware corporation (the “
Company
”), declared a dividend of one preferred share purchase
right (each, a “
Right
”) for each outstanding share of common stock, par value $0.0001, of the Company (the
“
Common Stock
”). The dividend is payable to stockholders of record of the Company as of the close of business
on August 25, 2016 (the “
Record Date
”).
This summary of rights provides only a
general description and should be read together with the Tax Asset Protection Plan, dated as of August 11, 2016, between the Company
and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “
Plan
”). All capitalized terms used
herein but not defined herein shall have the meanings ascribed to such terms in the Plan.
The Plan was adopted in an effort to protect
stockholder value by attempting to diminish the risk that the Company’s ability to use its net operating losses (the “
Tax
Attributes
”) to reduce potential future federal income tax obligations may become substantially limited. The Company
has substantial Tax Attributes. Under the Internal Revenue Code and regulations promulgated by the U.S. Treasury Department, the
Company may carry forward or otherwise utilize these Tax Attributes in certain circumstances to offset any current and future
taxable income and thus reduce the Company’s federal income tax liability, subject to certain requirements and restrictions.
To the extent that the Tax Attributes do not otherwise become limited, the Company believes that it will have available a significant
amount of Tax Attributes in future years, and therefore these Tax Attributes could be a substantial asset to the Company. However,
if the Company experiences an “ownership change,” as defined in Section 382 of the Internal Revenue Code, its ability
to use the Tax Attributes may be substantially limited, and the timing of the usage of the Tax Attributes could be substantially
delayed, which could therefore significantly impair the value of that asset. A company experiences an “ownership change”
for tax purposes if the percentage of stock owned by its 5% stockholders (as defined for tax purposes) increases by more than
50 percentage points over a rolling three-year period.
The Plan is intended to act as a deterrent
to any person acquiring beneficial ownership of 4.9% or more of the Company’s outstanding Common Stock without the approval
of the Board. Stockholders who beneficially own 4.9% or more of the Company’s outstanding Common Stock upon execution of
the Plan will not trigger the Plan so long as they do not acquire beneficial ownership of additional shares of Common Stock. The
Board may, in its sole discretion, also exempt any person from triggering the Plan.
The
Rights
. One Right will be issued for each outstanding share of Common Stock to stockholders of record as of the close
of business on August 25, 2016. One Right will also be issued together with each share of Common Stock issued after August 25,
2016 but before the Distribution Date (as defined below) and, in certain circumstances, after the Distribution Date. Subject to
the terms, provisions and conditions of the Plan, if the Rights become exercisable, each Right would initially represent the right
to purchase from the Company one ten-thousandth of a share of the Company’s Series D Junior Participating Preferred Stock,
par value $0.0001 per share (the “
Series D Preferred Stock
”) for a purchase price of $14.00 (the “
Purchase
Price
”). If issued, each fractional share of Series D Preferred Stock would give the stockholder approximately the same
dividend, voting and liquidation rights as does one share of Common Stock. However, prior to exercise, a Right does not give its
holder any rights as a stockholder of the Company, including, without limitation, any dividend, voting or liquidation rights.
Initial
Exercisability
. The Rights will not be exercisable until the earlier of (i) ten business days after a public announcement
that a person has become an “Acquiring Person” by acquiring beneficial ownership of 4.9% or more of the Company’s
outstanding Common Stock, or, in the case of a person that had beneficial ownership of 4.9% or more of the Company’s outstanding
Common Stock upon execution of the Plan, by obtaining beneficial ownership of additional shares of Common Stock or (ii) ten
business days (or such later date as may be specified by the Board prior to such time as any person becomes an Acquiring Person)
after the commencement of a tender or exchange offer by or on behalf of a person that, if completed, would result in such person
becoming an Acquiring Person.
The date that the Rights become
exercisable is referred to as the “
Distribution Date
.” Until the Distribution Date, Common Stock
certificates or the ownership statements issued with respect to uncertificated shares of Common Stock will evidence the
Rights. Any transfer of shares of Common Stock prior to the Distribution Date will also constitute a transfer of the
associated Rights. After the Distribution Date, separate rights certificates will be issued and the Rights may be transferred
other than in connection with the transfer of the underlying shares of Common Stock unless and until the Board has determined
to effect an exchange pursuant to the Plan (as described below).
Flip-In
Event
. In the event that a person becomes an Acquiring Person, each holder of a Right, other than Rights that are or,
under certain circumstances, were beneficially owned by the Acquiring Person (which will thereupon become null and void), will
thereafter have the right to receive upon exercise of a Right and payment of the Purchase Price, a number of shares of Common
Stock having a market value of two times the Purchase Price.
Redemption.
At any time until a person becomes an “Acquiring Person”, the Board may redeem the Rights in whole, but
not in part, at a price of $0.00001 per Right (the “
Redemption Price
”). The redemption of the Rights may be
made effective at such time, on such basis and with such conditions as the Board in its sole discretion may establish. Immediately
upon any redemption of the Rights, the right to exercise the Rights will terminate and the only right of the holders of Rights
will be to receive the Redemption Price.
Exchange
.
At any time after a person becomes an Acquiring Person, the Board may exchange the Rights (other than Rights that have become
null and void), in whole or in part, at an exchange ratio of one share of Common Stock, or a fractional share of Series D Preferred
Stock (or of a share of a similar class or series of the Company’s preferred stock having similar rights, preferences and
privileges) of equivalent value, per Right (subject to adjustment). Immediately upon an exchange of any Rights, the right to exercise
such Rights will terminate and the only right of the holders of Rights will be to receive the number of shares of Common Stock
(or fractional share of Series D Preferred Stock or of a share of a similar class or series of the Company’s preferred stock
having similar rights, preferences and privileges) equal to the number of such Rights held by such holder multiplied by the exchange
ratio. The Board shall not be empowered to effect such exchange at any time after an Acquiring Person becomes the beneficial owner
of 50% or more of the Company’s outstanding Common Stock.
Expiration
.
The Rights and the Plan will expire on the earlier of (i) the Close of Business on the earlier of (a) August 11, 2019, or
(b) August 11, 2017 if stockholder approval of the Plan has not been received by or on such date, (ii) the time at which
the Rights are redeemed pursuant to the Plan, (iii) the time at which the Rights are exchanged in full pursuant to the Plan,
(iv) the effective date of the repeal of both Section 382 and Section 383 of the Internal Revenue Code, or any successor
provisions or replacement provisions, if the Board determines that the Plan is no longer necessary for the preservation of Tax
Benefits or (v) the beginning of a taxable year of the Company for which the Board determines that the Company has or will
have no Tax Benefits.
Anti-Dilution
Provisions
. The Board may adjust the Purchase Price, the number of shares of Series D Preferred Stock or other securities
or assets issuable and the number of outstanding Rights to prevent dilution that may occur as a result of certain events, including
among others, a stock dividend, a stock split or a reclassification of the Series D Preferred Stock or Common Stock. With certain
exceptions, no adjustments to the Purchase Price will be required until cumulative adjustments amount to at least 1% of the Purchase
Price.
Amendments
.
For so long as the Rights are redeemable, the Board may supplement or amend any provision of the Plan in any respect without the
approval of the holders of the Rights. From and after the time the Rights are no longer redeemable, the Board may supplement or
amend the Plan only to cure an ambiguity, to alter time period provisions, to correct inconsistent provisions, or to make any
additional changes to the Plan which the Company may deem necessary or desirable, but only to the extent that those changes do
not impair or adversely affect any Rights holder (other than an Acquiring Person or any Affiliate or Associate of an Acquiring
Person or certain of their transferees) and do not result in the Rights again becoming redeemable or the Plan again becoming amendable
other than in accordance with this sentence.
The following exhibits are filed as a part
of this Registration Statement:
Exhibit
No.
|
|
Description
|
3.1
|
|
Certificate of Designation, Preferences, and
Rights of Series D Junior Participating Preferred Stock of BioScrip, Inc. (incorporated by reference to Exhibit 3.1 to the
Form 8-K (File No. 000-28740) filed by BioScrip, Inc. with the SEC on August 12, 2016).
|
|
|
|
4.1
|
|
Tax Asset Protection Plan dated as of August 11, 2016, by and between the Company and American Stock Transfer & Trust
Company, LLC, as rights agent, which includes as Exhibit B the Form of Rights Certificate (incorporated by reference to Exhibit
4.1 to the Form 8-K (File No. 000-28740) filed by BioScrip, Inc. with the SEC on August 12, 2016).
|
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
Date: August 12, 2016
|
BIOSCRIP, INC.
|
|
|
|
|
|
By:
|
/s/ Kathryn M. Stalmack
|
|
|
Name:
|
Kathryn M. Stalmack
|
|
|
Title:
|
Senior Vice President, General
|
|
|
|
Counsel and Secretary
|
EXHIBIT INDEX
Exhibit
No.
|
|
Description
|
3.1
|
|
Certificate of Designation, Preferences, and
Rights of Series D Junior Participating Preferred Stock of BioScrip, Inc. (incorporated by reference to Exhibit 3.1 to the
Form 8-K (File No. 000-28740) filed by BioScrip, Inc. with the SEC on August 12, 2016).
|
|
|
|
4.1
|
|
Tax Asset Protection Plan
dated as of August
11, 2016, by and between the Company and American Stock Transfer & Trust Company, LLC, as rights agent, which
includes as Exhibit B the Form of Rights Certificate (incorporated by reference to Exhibit 4.1 to the Form 8-K (File
No. 000-28740) filed by BioScrip, Inc. with the SEC on August 12, 2016).
|
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Sep 2023 to Sep 2024